BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9470329)

  • 1. Maintenance therapy with itraconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome.
    Chotmongkol V; Sukeepaisarncharoen W
    J Med Assoc Thai; 1997 Dec; 80(12):767-70. PubMed ID: 9470329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of itraconazole with initial flucytosine in AIDS-related cryptococcal meningitis: a preliminary study.
    Riantawan P; Ponglertnapakorn P
    J Med Assoc Thai; 1996 Jul; 79(7):429-33. PubMed ID: 8855621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
    Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK
    Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
    Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
    Graybill JR
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():26-30. PubMed ID: 9441302
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
    J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS.
    Chotmongkol V; Sukeepaisarncharoen W; Thavornpitak Y
    J Med Assoc Thai; 1997 Jul; 80(7):416-25. PubMed ID: 9277070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole in the treatment of cryptococcal meningitis.
    Chotmongkol V; Jitpimolmard S
    J Med Assoc Thai; 1992 Feb; 75(2):85-8. PubMed ID: 1322948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial response: A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.
    Larsen RA
    Clin Infect Dis; 1999 Feb; 28(2):297-8. PubMed ID: 10064247
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole.
    Schaars CF; Meintjes GA; Morroni C; Post FA; Maartens G
    BMC Infect Dis; 2006 Jul; 6():118. PubMed ID: 16846523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial treatment of cryptococcal meningitis in AIDS.
    Chotmongkol V; Arayawichanont A; Sawanyawisuth K; Thavornpitak Y
    Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):170-3. PubMed ID: 15906662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
    Mussini C; Pezzotti P; Miró JM; Martinez E; de Quiros JC; Cinque P; Borghi V; Bedini A; Domingo P; Cahn P; Bossi P; de Luca A; d'Arminio Monforte A; Nelson M; Nwokolo N; Helou S; Negroni R; Jacchetti G; Antinori S; Lazzarin A; Cossarizza A; Esposito R; Antinori A; Aberg JA;
    Clin Infect Dis; 2004 Feb; 38(4):565-71. PubMed ID: 14765351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Itraconazole in systemic fungal infections. Clinical profile and future trends].
    Fernández Fernández A; Esteban Montero S
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():66-70. PubMed ID: 9441309
    [No Abstract]   [Full Text] [Related]  

  • 15. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
    Sungkanuparph S; Filler SG; Chetchotisakd P; Pappas PG; Nolen TL; Manosuthi W; Anekthananon T; Morris MI; Supparatpinyo K; Kopetskie H; Kendrick AS; Johnson PC; Sobel JD; Larsen RA
    Clin Infect Dis; 2009 Sep; 49(6):931-4. PubMed ID: 19681708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and adverse effects of higher dose amphotericin B monotherapy for cryptococcal meningitis in patients with advanced HIV infection.
    Hsieh SM; Hung CC; Chen MY; Hsueh PR; Chang SC
    J Microbiol Immunol Infect; 1998 Dec; 31(4):233-9. PubMed ID: 10496164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cryptococcal meningitis with triple combination of amphotericin B, flucytosine and itraconazole.
    Chotmongkol V; Jitpimolmard S
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):381-3. PubMed ID: 8629082
    [No Abstract]   [Full Text] [Related]  

  • 18. Cryptococcal disease in HIV infection: treatment and maintenance.
    Fisher M; Price DA; Klein J; Weston R; Coker RJ
    AIDS; 1995 Mar; 9(3):300-1. PubMed ID: 7755921
    [No Abstract]   [Full Text] [Related]  

  • 19. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
    de Gans J; Portegies P; Tiessens G; Eeftinck Schattenkerk JK; van Boxtel CJ; van Ketel RJ; Stam J
    AIDS; 1992 Feb; 6(2):185-90. PubMed ID: 1313682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.